Edwards Lifesciences
(NYSE) EW
Edwards Lifesciences Financials at a Glance
Market Cap
$52.27B
Revenue (TTM)
$6.30B
Net Income (TTM)
$1.09B
EPS (TTM)
$1.84
P/E Ratio
49.32
Dividend
$0.00
Beta (Volatility)
0.86 (Low)
Dividend
$0.00
Beta (Volatility)
0.86 (Low)
Price
$91.33
Volume
86,432
Open
$91.16
Price
$91.33
Volume
86,432
Open
$91.16
Previous Close
$91.33
Daily Range
$91.02 - $92.81
52-Week Range
$72.30 - $92.81
Estimated Earnings Date
Jul 23, 2026
Dividend
$0.00
Beta (Volatility)
0.86 (Low)
Price
$91.33
Volume
86,432
Open
$91.16
Previous Close
$91.33
Daily Range
$91.02 - $92.81
52-Week Range
$72.30 - $92.81
Estimated Earnings Date
Jul 23, 2026
EW News
EW: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Edwards Lifesciences
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
16,000
CEO
Bernard J. Zovighian, MBA
Website
www.edwards.comHeadquarters
Irvine, CA 92614, US
EW Financials
Key Financial Metrics (TTM)
Gross Margin
78.01%
Operating Margin
27.62%
Net Income Margin
17.34%
Return on Equity
10.55%
Return on Capital
14.82%
Return on Assets
8.20%
Earnings Yield
2.03%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$52.27B
Shares Outstanding
575.80M
Volume
86.43K
Avg. Volume
5.22M
Financials (TTM)
Gross Profit
$4.92B
Operating Income
$1.74B
EBITDA
$1.42B
Operating Cash Flow
$1.36B
Capital Expenditure
-$269.10M
Free Cash Flow
$1.09B
Cash & ST Invst.
$3.67B
Total Debt
$702.90M
Edwards Lifesciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.65B
+16.7%
Gross Profit
$1.29B
+16.0%
Gross Margin
78.21%
N/A
Market Cap
$52.27B
N/A
Market Cap/Employee
$3.31M
N/A
Employees
15,800
N/A
Net Income
$380.70M
+6.3%
EBITDA
$499.90M
+6.2%
Quarterly Fundamentals
Total Cash
$3.67B
-5.8%
Total Debt
$702.90M
+0.5%
Accounts Receivable
$973.00M
+29.4%
Inventory
$1.12B
+0.5%
Long Term Debt
$678.60M
+0.4%
Short Term Debt
$24.30M
+2.5%
Return on Assets
8.20%
N/A
Return on Invested Capital
14.62%
N/A
Free Cash Flow
-$21.10M
-109.4%
Operating Cash Flow
$43.80M
-84.4%